

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Adagrasib iyimithi yomdlavuza eqondiswe ngqo evimbela amaprotheni athile asiza ukukhula kwamanye amathumba. Yenzelwe ukwelapha umdlavuza wamaphaphu oqhubekayo kanye nomdlavuza we-colorectal othwala uguquko oluthile lofuzo olubizwa nge-KRAS G12C. Le mithi yomlomo imelela ukuqanjwa okusha emithini eqondile, inikeza ithemba ezigulini ezinomdlavuza obekunzima ukuwelapha ngemithi yendabuko.
I-Adagrasib iyisidakamizwa somdlavuza esinconywayo esingaphansi kwezigaba ezibizwa ngokuthi ama-KRAS G12C inhibitors. Isebenza ngokugxila nokuvimba iprotheni eguquliwe eqhuba ukukhula kwamaseli omdlavuza ezinhlotsheni ezithile zamathumba. Le mithi yathuthukiswa ngqo ngomdlavuza ohlolwa ukuthi unegciwane le-KRAS G12C, elenzeka cishe kuma-13% omdlavuza wamaphaphu kanye nama-3% omdlavuza we-colorectal.
Le mithi ithathwa njengokwelashwa okuqondiswe ngqo kunokwelashwa ngamakhemikhali endabuko. Ngokungafani nokwelashwa ngamakhemikhali okuthinta amaseli anempilo nawomdlavuza, i-adagrasib iqondise ngqo iprotheni ye-KRAS eguquliwe etholakala kuphela kumaseli omdlavuza. Le ndlela eqondile ivame ukuholela emiphumeleni emincane eceleni uma iqhathaniswa nokwelashwa komdlavuza okuvamile.
I-Adagrasib isetshenziselwa ikakhulukazi ukwelapha izinhlobo ezimbili ezithile zomdlavuza oqhubekayo kubantu abadala. Udokotela wakho uzonikeza le mithi kuphela uma ithumba lakho lihlolwa ukuthi line-KRAS G12C mutation ngokuhlolwa okukhethekile kofuzo.
Le mithi iphatha umdlavuza wamaphaphu ongawona amancane oselulele kwezinye izingxenye zomzimba wakho noma ongenakususwa ngokuhlinzwa. Ivunyelwe ngqo ezigulini ebezivele zizame okungenani enye indlela yokwelapha yesistimu. Iziguli eziningi ezinalesi sifo somdlavuza wamaphaphu bezinezinketho ezilinganiselwe zokwelashwa ngaphambi kokuba i-adagrasib itholakale.
I-Adagrasib iphinda iphathe umdlavuza wamathumbu oqhubekayo osabalale ngaphandle kwamathumbu amakhulu noma i-rectum. Ngomdlavuza wamathumbu, isetshenziswa uma umdlavuza usuthuthuke ngemva kokwelashwa ngama-regimen e-chemotherapy asekelwe ku-fluoropyrimidine, asekelwe ku-oxaliplatin, kanye nasekelwe ku-irinotecan. Lokhu kumelela intuthuko enkulu ezigulini ezinomdlavuza wamathumbu we-KRAS G12C-positive, ebezinesiphumo esibi sokwelashwa ngaphambilini.
I-Adagrasib isebenza ngokuvimba iphrotheni ye-KRAS G12C esebenza njengoshintsho olungahambi kahle emangqamuzaneni omdlavuza. Emangqamuzaneni anempilo, iphrotheni ye-KRAS ngokuvamile isiza ukulawula ukukhula nokuhlukaniswa kwamangqamuzana. Lapho le phrotheni iguquka ibe yi-KRAS G12C, ibambeka endaweni ethi "ivuliwe", okwenza amangqamuzana akhule futhi ahlukaniswe ngaphandle kokulawulwa.
Lo muthi ubhekwa njengokwelashwa okuqondiwe okuqinile nokucacile kakhulu. Ubopha ngokuqondile kuphrotheni eguquliwe ye-KRAS G12C futhi uyikhiya esimweni esingasebenzi. Lokhu kumisa amangqamuzana omdlavuza ekutholeni amasignali abawadingayo ukuze akhule futhi aphindaphindeke, okungenzeka anciphise izinso noma anciphise ukukhula kwawo.
Ngokungafani nokwelashwa komdlavuza okubanzi, ukugxila okunembile kwe-adagrasib kusho ukuthi ikakhulukazi kuthinta amangqamuzana omdlavuza ngenkathi ishiya amangqamuzana anempilo engaphazamisekile kakhulu. Le ndlela ekhethiwe ivame ukuholela ekubekezeleni okungcono kanye nemiphumela emibi embalwa uma iqhathaniswa nama-regimen e-chemotherapy yendabuko.
I-Adagrasib iza ngamaphilisi owathatha ngomlomo kabili ngosuku, cishe ngamahora ayi-12 ahlukene. Umthamo ojwayelekile ungu-600 mg kabili ngosuku, okulingana namaphilisi amane e-150 mg ngaso sonke isikhathi. Udokotela wakho angase alungise umthamo wakho ngokusekelwe endleleni ozabela ngayo ekwelashweni kanye nanoma yimiphumela emibi oyitholayo.
Kufanele uthathe i-adagrasib ngokudla ukuze usize umzimba wakho ukumunca imithi kahle. Ukudla ukudla noma ukudla okulukhuni uma uthatha umthamo wakho kunganciphisa ukuphazamiseka kwesisu futhi kuthuthukise ukuthi imithi isebenza kanjani. Zama ukuthatha imithamo yakho ngezikhathi ezifanayo nsuku zonke ukuze ugcine amazinga aqhubekayo egazini lakho.
Gwinya amaphilisi wonke ngengilazi yamanzi egcwele. Ungawachobozi, uwahlafune, noma uwaqhekeze amaphilisi, ngoba lokhu kungathinta ukuthi imithi ikhishwe kanjani emzimbeni wakho. Uma unenkinga yokugwinya amaphilisi, khuluma nethimba lakho lezempilo ngamasu angase asize.
Gwema ama-grapefruit nejusi le-grapefruit ngenkathi uthatha i-adagrasib, ngoba lokhu kungaphazamisa ukuthi umzimba wakho usebenza kanjani ngemithi. Futhi, yazisa udokotela wakho ngeminye imithi noma izithasiselo ozithathayo, njengoba ezinye zingasebenzisana ne-adagrasib.
Ngokuvamile uzoqhubeka nokuthatha i-adagrasib uma nje isiza ukulawula umdlavuza wakho futhi uyayibekezelela kahle. Lokhu kungaba izinyanga noma iminyaka, kuye ngokuthi umdlavuza wakho usabela kanjani ekwelashweni. Udokotela wakho uzohlola njalo inqubekela phambili yakho ngokusebenzisa izithombe nokuhlolwa kwegazi ukuze anqume ukuthi imithi iyasebenza yini.
Ubude bokwelashwa buhluka kakhulu kumuntu nomuntu ngokuya ngezici eziningana. Ezinye iziguli zingase zidinge ukulungiswa komthamo noma ukuphumula okwesikhashana uma ziba nemiphumela emibi. Abanye bangase baqhubeke ngomthamo ofanayo isikhathi eside uma umdlavuza wabo uhlala uzinzile noma unciphile.
Udokotela wakho we-oncologist uzohlela ukuhlolwa okuvamile ukuze ahlulele ukusabela kwakho ekwelashweni futhi aqaphele noma yiziphi izinguquko ezikhathazayo. Lawa ma-aphoyintimenti ngokuvamile ahlanganisa ukuhlolwa komzimba, umsebenzi wegazi, kanye nezithombe zokuhlola njalo ezinyangeni ezimbalwa. Ngokuya ngemiphumela, udokotela wakho uzoqoka ukuthi uzoqhubeka, uguqule, noma umise ukwelashwa kwakho kwe-adagrasib.
Njengazo zonke izidakamizwa zomdlavuza, i-adagrasib ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Imiphumela eminingi emibi ingalawuleka ngokunakekelwa okufanele kwezokwelapha nokuqapha. Ithimba lakho lezempilo lizosebenza eduze nawe ukuvimbela noma ukunciphisa noma yiziphi izimpawu ezingakhululeki.
Imiphumela emibi evame kakhulu abantu abaningi abayitholayo ihlanganisa ukukhathala, isicanucanu, nohudo. Lokhu kuvame ukuthuthuka emasontweni ambalwa okuqala okwelashwa njengoba umzimba wakho ujwayela umuthi:
Le miphumela emibi ejwayelekile ivame ukuba milde kuya kokulingene futhi ivame ukuthuthuka njengoba umzimba wakho ujwayela ukwelashwa. Udokotela wakho angakwazi ukunikeza imithi yokusiza ukulawula isicanucanu nohudo uma kudingeka.
Ezinye iziguli zingase zibe nemiphumela emibi ebucayi edinga ukunakekelwa kwezokwelapha ngokushesha. Nakuba lokhu kungavamile, kubalulekile ukukubona kusenesikhathi:
Xhumana nethimba lakho lezempilo ngokushesha uma uhlangabezana nanoma yiziphi lezi zimpawu ezingathi sína. Bangakunikeza isiqondiso sokulawula imiphumela emibi futhi bangase balungise uhlelo lwakho lokwelashwa uma kudingeka.
I-Adagrasib ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ilungile yini kuwe. Izimo ezithile zezokwelapha noma izimo zingenza lo muthi ungaphephile noma ungasebenzi kahle esimweni sakho esithile.
Akufanele uthathe i-adagrasib uma ukhulelwe noma uhlela ukukhulelwa. Lo muthi ungalimaza umntwana osakhulayo, ngakho-ke ukuhlela umndeni okuthembekile kubalulekile ngesikhathi sokwelashwa kanye namasonto amaningana ngemuva kokuyeka. Abesifazane abaneminyaka yokuzala bazodinga ukuhlolwa kokukhulelwa ngaphambi kokuqala ukwelashwa.
Omama abancelisa abantwana akufanele bathathe i-adagrasib, njengoba umuthi ungangena obisini futhi ungalimaza ingane encelisayo. Udokotela wakho uzoxoxa ngezindlela zokudla eziphephile uma udinga lokhu kwelashwa ngenkathi unomntwana omncane.
Abantu abanezinkinga ezinkulu zesibindi kungenzeka bangakwazi ukuthatha i-adagrasib ngokuphepha, njengoba umuthi ucubungulwa esibindini. Udokotela wakho uzohlola ukusebenza kwesibindi sakho ngokuhlolwa kwegazi ngaphambi kokuqala ukwelashwa futhi akuqaphele njalo ngesikhathi sokwelashwa kwakho.
Uma uthatha imithi ethile esebenzisana ne-adagrasib, udokotela wakho kungadingeka alungise imithamo noma akhethe ezinye izindlela zokwelapha. Lokhu kufaka phakathi ezinye izinciphisi zegazi, imithi yenhliziyo, neminye imithi yomdlavuza. Nqamula uhlinzeke ithimba lakho lezempilo ngohlu oluphelele lwazo zonke izidakamizwa nezithasiselo ozithathayo.
I-Adagrasib ithengiswa ngaphansi kwegama lomkhiqizo elithi Krazati e-United States. Leli yilo kuphela igama lomkhiqizo elitholakalayo njengamanje ngalo muthi, njengoba kuyindlela yokwelapha entsha eqondiswe ngqo esanda kuvunywa yi-FDA.
Lapho uthatha umuthi wakho, uzobona i-
Kubantu abanezifo ezinomdlavuza we-KRAS G12C-positive, i-adagrasib iyingxenye yeqembu elisha lezindlela zokwelapha ezihloswe ngazo, kodwa akuyona yona kuphela inketho etholakalayo. I-Sotorasib (igama lomkhiqizo elithi Lumakras) ngomunye umvimbi we-KRAS G12C osebenza ngendlela efana ne-adagrasib futhi ingase icatshangelwe njengenye indlela yokwelapha.
Uma ukwelashwa okuhloswe ngakho kungafaneleki esimweni sakho, udokotela wakho we-oncologist angase ancome izindlela zokwelapha ngamakhemikhali zendabuko. Lokhu kungabandakanya izinhlanganisela zokwelapha ngamakhemikhali ezisekelwe ku-platinum, imithi yokwelapha ngomzimba njenge-pembrolizumab, noma ezinye izindlela zokwelapha ezihloswe ngazo kuye ngamanye ama-genetic markers umdlavuza wakho ongase awathwale.
Izivivinyo zomtholampilo zingase futhi zinikeze ukufinyelela ekwelashweni okusha okungokwesipiliyoni kwemidlavuza ye-KRAS G12C-positive. Udokotela wakho angakusiza ukuthi uhlole ukuthi ungazuza yini ekuhlanganyeleni ocwaningweni oluhlola ukwelashwa okuhlanganisiwe noma izivimbeli ze-KRAS zesizukulwane esilandelayo.
Kokubili i-adagrasib ne-sotorasib zihlose ukuguqulwa okufanayo kwe-KRAS G12C, kodwa zinezinye izinto ezingase zenze enye ifaneleke kakhulu esimweni sakho esithile. Ucwaningo luphakamisa ukuthi i-adagrasib ingase ibe nokungena okungcono ebuchosheni, okungase kubaluleke uma unomdlavuza oye wasabalala ebuchosheni.
Amaphrofayili emiphumela emibi afana phakathi kwemithi emibili, nakuba ezinye iziguli zingase zikwazi ukubekezelela enye kangcono kunenye. I-Adagrasib ithathwa kabili ngosuku, kuyilapho i-sotorasib ithathwa kanye ngosuku, okungase kuthinte okuthandayo ngokuya ngendlela yakho yokuphila neshejuli yakho.
Udokotela wakho we-oncologist uzocabangela izinto ezinjengempilo yakho yonke, izinga lomdlavuza wakho, ukwelashwa kwangaphambilini okutholile, kanye nezintandokazi zakho siqu lapho ukhetha phakathi kwalezi zinketho. Yomibili imithi imelela intuthuko enkulu ekwelapheni imidlavuza ye-KRAS G12C-positive, futhi ukukhetha okungcono kakhulu kuyahlukahluka kumuntu nomuntu.
I-Adagrasib ingasetshenziswa kubantu abanezifo zenhliziyo, kodwa idinga ukuqashwa ngokucophelela yithimba lakho lezempilo. Umuthi ungase ube nomthelela esigqi senhliziyo nomfutho wegazi, ngakho udokotela wakho cishe uzoqhuba izivivinyo zomsebenzi wenhliziyo ngaphambi kokuqala ukwelashwa futhi akuqaphele eduze ngesikhathi sokwelashwa.
Uma unomlando wezinkinga zenhliziyo, udokotela wakho wenhliziyo kanye nodokotela we-oncologist bazosebenzisana ukuqinisekisa ukuthi izinzuzo zokwelashwa komdlavuza zidlula noma yiziphi izingozi zenhliziyo nemithambo yegazi. Bangase batusa ukuqashwa kwenhliziyo okuvamile noma balungise eminye imithi oyithathayo yesimo senhliziyo yakho.
Uma ngengozi uthatha i-adagrasib eningi kunaleyo ebekiwe, xhumana nodokotela wakho noma isikhungo sokulawula ubuthi ngokushesha. Ungalindi ukubona ukuthi ngabe izimpawu ziyavela yini, njengoba ukuthatha okuningi kakhulu kungase kubangele imiphumela emibi engathi sína njengohudo olukhulu, izinkinga zesibindi, noma izinguquko eziyingozi ekubalweni kwegazi lakho.
Gcina umkhondo wokuthi uyithathe nini umthamo owengeziwe nokuthi uthathe okungakanani. Lolu lwazi luzosiza ithimba lakho lezempilo ukuthi linqume ukuthi yini okufanele yenziwe. Bangase bakufune ukuqashwa eduze noma balungise imithamo yakho elandelayo ehleliwe.
Uma uphuthelwa umthamo we-adagrasib, yithathe ngokushesha lapho ukhumbula, uma nje kungaphakathi kwamahora angu-6 esikhathi sakho esihleliwe. Uma sekudlule amahora angaphezu kwangu-6, weqa umthamo ophuthelwe bese uthatha umthamo wakho olandelayo ngesikhathi esijwayelekile. Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo ophuthelwe.
Zama ukugcina isimiso sakho somthamo esijwayelekile ngangokunokwenzeka, njengoba amazinga egazi aqhubekayo omuthi abalulekile ekusebenzeni. Cabangela ukusetha ama-alamu ocingo noma ukusebenzisa umhleli wamaphilisi ukukusiza ukuthi ukhumbule imithamo yakho.
Kufanele uyeke kuphela ukuthatha i-adagrasib ngaphansi kokuqondisa kukadokotela wakho. Lokhu kuvamile ukwenzeka lapho izithombe zibonisa ukuthi umdlavuza wakho awusaphenduli emithini, lapho imiphumela emibi iba nzima kakhulu ukuyilawula, noma lapho umdlavuza wakho ungena ekuxoleleni okuphelele futhi udokotela wakho enquma ukuthi kuphephile ukuyeka.
Ungalokothi uyeke ukuthatha i-adagrasib ngokwakho, ngisho noma uzizwa ungcono noma uneziphumela ezingezinhle. Ukuyeka kungazelelwe kungavumela umdlavuza wakho ukuthi ukhule ngokushesha. Uma unenkinga ngemiphumela emibi, khuluma nethimba lakho lezempilo ngezindlela zokuyilawula kunokuyeka ukwelashwa.
I-Adagrasib ivame ukusetshenziswa njenge-ejenti eyodwa, kodwa udokotela wakho angase ayihlanganise nezinye izindlela zokwelapha kuye ngesimo sakho esithile. Ezinye iziguli ziyayithola kanye nemithi yokunakekela noma i-radiation therapy ezindaweni ezithile lapho umdlavuza usabalale khona.
Ukuhlanganisa i-adagrasib neminye imithi yomdlavuza kudinga ukuhlelwa nokuqapha ngokucophelela, njengoba ukusebenzisana kungathinta ukuthi imithi ngayinye isebenza kahle kangakanani noma yandise imiphumela emibi. Udokotela wakho we-oncologist uzoklama uhlelo lokwelapha olwandisa izinzuzo ngenkathi kunciphisa izingozi ngokusekelwe ocwaningweni lwakamuva kanye nezidingo zakho.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.